Ascent Solar outlines 2026 strategy after forming defense partnerships

Ascent Solar Technologies Inc. (NASDAQ: ASTI) outlined its 2026 business strategy following what the company described as commercial progress and new partnerships established in 2025, according to a company statement.

The Thornton, Colorado-based thin-film solar panel manufacturer reported forming strategic partnerships with NovaSpark, Emtel Energy, CisLunar Industries, Defiant Space, Star Catcher Industries, and NOVI Space during 2025. The company also established rapid delivery capabilities for civil and defense space missions and completed a private placement of up to $5.5 million in December 2025.

"The defense industry has displayed an increasing demand for efficient, readily available technologies; we have made ourselves an ideal provider by offering a highly efficient product, produced in the United States, that is ready for rapid delivery," said Paul Warley, CEO of Ascent Solar Technologies.

The company reported advancing its thin-film photovoltaic product capabilities in 2025, including space-based power beaming abilities, marine environment durability, and hydrogen production through field-based hydrolyzers. Ascent also partnered with the Georgia Institute of Technology to apply thin-film technology to unmanned aerial vehicle wings for ocean monitoring demonstrations.

For 2026, Ascent plans to begin the year with production scheduled to deliver on existing orders for array deployments in the first quarter. CEO Warley traveled to Europe in January to establish potential partnerships and customer relationships. The company plans to develop and deliver UAV arrays for European partners in the first half of 2026.

Additional 2026 goals include advancing the efficiency of the company's CIGS thin-film technology and conducting environmental testing through the first quarter to measure performance in space conditions, including radiation and atomic oxygen resilience testing.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Devonian Health Group plans NYSE American listing under DHGR
• 37 Capital raises $300,000 in partial private placement closing